Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer

NCT02491983 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

486

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Palbociclib
DRUG: Fulvestrant
DRUG: Letrozole

Sponsor

MedSIR